Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNatwest Regulatory News (NWG)

Share Price Information for Natwest (NWG)

Share Price is delayed by 15 minutes
Get Live Data
609.60    22.00 (3.74%)
Bid:
609.60
Ask:
609.80
Spread: 0.20 (0.033%)
Market Cap: £48.53b
NWG Live PriceLast checked at - London Stock Exchange

Intraday Natwest Share Chart

NatWest Group–Segmental reporting re-presentation

22 Apr 2022 08:00

RNS Number : 0327J
NatWest Group plc
22 April 2022
 

 

 

 

 

NatWest Group plc 22 April 2022

NatWest Group - Segmental reporting re-presentation

NatWest Group plc ("NatWest Group") has today published details of the change in operating segments that it announced on 27 January 2022 (https://www.natwestgroup.com/news/2022/01/natwest-group-brings-together-new-commercial-institutional-franchise.html). Previously reported financial information has been re-presented in the new operating segments to aid comparison of NatWest Group's forthcoming Q1 2022 results with prior periods. The re-presentation does not change the consolidated financial results of NatWest Group.

On 27 January 2022, NatWest Group announced that a new franchise, Commercial & Institutional, would be created, bringing together the Commercial, NatWest Markets and RBS International businesses to form a single franchise with common management and objectives, to best support our customers across the full non-personal customer lifecycle.

NatWest Group's operating segments are now:

- Retail Banking

- Private Banking

- Commercial & Institutional

- Central items and other

- Ulster Bank RoI

 

Financial information for the years 2019, 2020, and 2021 and the nine quarters from Q4 2019 to Q4 2021 are re-presented in the attached financial supplement http://www.rns-pdf.londonstockexchange.com/rns/0327J_1-2022-4-22.pdf which is also available to view and download at https://investors.natwestgroup.com/.

NatWest Group's Q1 2022 results will be announced on 29 April 2022 and will be presented under the new operating segment structure.

For further information, please contact:

Alexander HolcroftInvestor Relations+44 (0) 207 672 1758

NatWest Group Press Office+44 (0) 131 523 4205

Legal Entity Identifier: 2138005O9XJIJN4JPN90

Forward-looking statements

This document contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, such as statements that include, without limitation, the words 'expect', 'estimate', 'project', 'anticipate', 'commit', 'believe', 'should', 'intend', 'will', 'plan', 'could', 'probability', 'risk', 'Value-at-Risk (VaR)', 'target', 'goal', 'objective', 'may', 'endeavour', 'outlook', 'optimistic', 'prospects' and similar expressions or variations on these expressions. These statements concern or may affect future matters, such as NatWest Group's future economic results, business plans and strategies.  In particular, this document may include forward-looking statements relating to NatWest Group plc in respect of, but not limited to: its creation of the Commercial & Institutional franchise and the intended benefits of the Commercial & Institutional franchise, the impact of the Covid-19 pandemic, its regulatory capital position and related requirements, its financial position, profitability and financial performance (including financial, capital, cost savings and operational targets), the implementation of its Purpose-led strategy, its ESG and climate related targets, its access to adequate sources of liquidity and funding, increasing competition from new incumbents and disruptive technologies, its exposure to third party risks, its ongoing compliance with the UK ring-fencing regime and ensuring operational continuity in resolution, its impairment losses and credit exposures under certain specified scenarios, substantial regulation and oversight, ongoing legal, regulatory and governmental actions and investigations, the transition of LIBOR and IBOR rates to alternative risk free rates and NatWest Group's exposure to economic and political risks (including with respect to terms surrounding Brexit and climate change), operational risk, conduct risk, cyber, data and IT risk, financial crime risk, key person risk and credit rating risk.  Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, the impact of the Covid-19 pandemic, future growth initiatives (including acquisitions, joint ventures and strategic partnerships), the outcome of legal, regulatory and governmental actions and investigations, the level and extent of future impairments and write-downs (including with respect to goodwill), legislative, political, fiscal and regulatory developments, accounting standards, competitive conditions, technological developments, interest and exchange rate fluctuations, general economic and political conditions and the impact of climate-related risks and the transitioning to a net zero economy. These and other factors, risks and uncertainties that may impact any forward-looking statement or NatWest Group plc's actual results are discussed in NatWest Group plc's UK 2021 Annual Report and Accounts (ARA) and NatWest Group plc's filings with the US Securities and Exchange Commission, including, but not limited to, NatWest Group plc's most recent Annual Report on Form 20-F and Reports on Form 6-K. The forward-looking statements contained in this document speak only as of the date of this document and NatWest Group plc does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this document, whether as a result of new information, future events or otherwise, except to the extent legally required.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFZGZDVZNGZZG
Date   Source Headline
3rd Jan 20252:00 pmRNSDirector/PDMR Shareholding
31st Dec 20241:06 pmRNSTotal Voting Rights
13th Dec 202411:15 amRNSAppointment of Chief Governance Officer
13th Dec 202410:30 amRNSHolding(s) in Company - HMT
13th Dec 20249:00 amRNSDirectorate Change
6th Dec 20241:47 pmRNSPublication of Prospectus
29th Nov 202412:44 pmRNSTotal Voting Rights
26th Nov 20242:00 pmRNSDirector/PDMR Shareholding
22nd Nov 202410:30 amRNSHolding(s) in Company – HMT shareholding
21st Nov 202410:10 amRNSHolding(s) in Company Capital Group Companies Inc.
18th Nov 20244:24 pmRNSDividend Declaration
18th Nov 20243:00 pmRNSDirector/PDMR Shareholding
15th Nov 20249:41 amRNSNatWest Group plc Filing of Registration Statement
13th Nov 20241:36 pmRNSHolding(s) in Company - HMT Shareholding
13th Nov 20241:11 pmRNSTotal Voting Rights
12th Nov 20242:00 pmRNSDirector/PDMR Shareholding
12th Nov 20247:00 amRNSQ3 2024 Pillar 3
11th Nov 20247:01 amRNSOff-Market Purchase of Ordinary Shares from HMT
11th Nov 20247:00 amRNSDisposal of Shares in NatWest Group plc for £1bn
8th Nov 20242:00 pmRNSDirector/PDMR Shareholding
6th Nov 20241:18 pmRNSNotice of Redemption
31st Oct 20241:02 pmRNSTotal Voting Rights
31st Oct 202410:30 amRNSHolding(s) in Company -HMT
25th Oct 20243:58 pmRNSPublication of Supplementary Prospectus
25th Oct 20247:00 amRNSNWG plc Q3 Results 2024
9th Oct 202410:30 amRNSHolding(s) in Company -HMT
2nd Oct 20244:00 pmRNSDirector/PDMR Shareholding
2nd Oct 202410:57 amRNSBlock Listing Six Monthly Return
30th Sep 20241:07 pmRNSTotal Voting Rights
27th Sep 202412:30 pmRNSDirector Declaration
26th Sep 20241:47 pmRNSNotice of Redemption
24th Sep 20248:00 amRNSBank of America Financials CEO Conference
23rd Sep 202410:30 amRNSHolding(s) in Company - HMT
17th Sep 20244:00 pmRNSDirector/PDMR Shareholding
13th Sep 20244:57 pmRNSPublication of Final Terms
11th Sep 20249:30 amRNSDirector Declaration
10th Sep 20246:02 pmRNSPublication of Final Terms
10th Sep 20243:00 pmRNSDirector/PDMR Shareholding
10th Sep 202412:00 pmRNSBarclays Global Financial Services Conference
30th Aug 202411:31 amRNSTotal Voting Rights
30th Aug 202410:30 amRNSHolding(s) in Company - HMT
13th Aug 202412:05 pmRNSNatWest Group plc Filing of Registration Statement
13th Aug 20247:18 amRNSH1 2024 Pillar 3
13th Aug 20247:00 amRNSQ1 2024 Pillar 3
8th Aug 20244:00 pmRNSDirector/PDMR Shareholding
7th Aug 202410:39 amRNSHolding(s) in Company - Norges Bank
6th Aug 20247:20 amRNS2024 NatWest Group resolvability assessment report
5th Aug 202410:30 amRNSHolding(s) in Company - HMT
1st Aug 20245:27 pmRNSPublication of Final Terms
1st Aug 20244:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.